FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Vemlidy (tenofovir alafenamide) from Gilead Sciences. This action updates the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vemlidy (tenofovir alafenamide)

Snippet

SUPPL AP for VEMLIDY (TENOFOVIR ALAFENAMIDE)